Gestala is a Chinese brain-computer interface startup developing non-invasive ultrasound-based BCI technology for chronic pain management. The company raised the largest early-stage BCI funding round in China ($21.6M angel round) in March 2026. Gestala's approach uses transcranial focused ultrasound to modulate neural activity in deep brain structures associated with pain perception, avoiding the need for surgical implantation.